Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.04K Hold
168
﹤0.01% 1236
2025
Q4
$4.91K Hold
168
﹤0.01% 888
2025
Q3
$4.39K Hold
168
﹤0.01% 910
2025
Q2
$3.78K Sell
168
-2
-1% -$41 ﹤0.01% 925
2025
Q1
$3.55K Hold
170
﹤0.01% 942
2024
Q4
$3.61K Hold
170
﹤0.01% 921
2024
Q3
$3.95K Hold
170
﹤0.01% 883
2024
Q2
$3.78K Hold
170
﹤0.01% 865
2024
Q1
$3.75K Hold
170
﹤0.01% 866
2023
Q4
$3.17K Buy
+170
New +$3.09K ﹤0.01% 860
2023
Q3
Sell
-60
Closed -$1.09K 598
2023
Q2
$1.09K Buy
+60
New +$1.04K ﹤0.01% 932

Other funds holding IX

CVA Family Office's IX Position: Q1 2026 in Review

CVA Family Office held its ORIX (IX) position steady in Q1 2026 at 168 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

CVA Family Office first reported a position in IX in Q2 2023 and has held it in 11 quarters since. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • CVA Family Office held 168 shares of ORIX worth $5.04K as of Q1 2026.
  • CVA Family Office left its ORIX share count unchanged in Q1 2026.
  • ORIX made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1236 holding.
  • CVA Family Office first reported a position in ORIX in Q2 2023 and has held it in 11 quarters since.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.